DOCSLIB.ORG

Neuroblastoma and Pheochromocytoma ALFRED G

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Amer J Hum Genet 24:514-532, 1972 Mutation and Cancer: Neuroblastoma and Pheochromocytoma ALFRED G. KNUDSON, JR.1 2 and LouISE C. STRONG' 3 A recent study of retinoblastoma [1] led to the conclusion that the occurrence of that tumor fits a two-mutation model. According to that model a fraction, fn, of all cases is nonhereditary and results from two somatic mutational events in one cell which is thereby transformed into a tumor cell, which, in turn, becomes a solitary primary tumor. The remaining fraction of cases, f7,, is hereditary and arises in indi- viduals who are predisposed to the tumor because they have inherited one of the mutational events, the second event occurring in one or more somatic cells; such individuals may develop one tumor, more than one, or none at all. These predisposed individuals most frequently acquire the first event as a fresh dominant mutation which has arisen in a parental germinal cell. They may present a family history of the tumor, they develop tumors earlier than do nonhereditary cases, and they may develop multiple tumors. In this report, we present an analysis of familial incidence, multiplicity, and age at diagnosis for two sympathetic-nervous-system tumors, neuroblastoma and pheochromocytoma, which reveals that these tumors also fit the two-mutation model. ANALYSIS OF DATA Neuroblastoma A starting point for the study was a review of the 60 cases of neuroblastoma seen at M. D. Anderson Hospital and Tumor Institute (MDAH) during the period 1944-1970. Two familial cases and three multiple primary cases were observed. These data were too few for analysis, so a literature review of the accumulated experience was undertaken. Points of special interest in the review were age at diagnosis, sex, multiplicity of tumors, and family incidence. In table 1 are presented the distribution of ages at diagnosis from a large series [2] of unselected cases. The largest group of cases (26%) occurs in the first year of life, following which the incidence tapers off, with 19% of cases coming after the age of 5 years. By contrast, familial cases [3-14] are clustered even more closely Received September 3, 1971: revised January 31, 1972. This work was supported in part by Public Health Service Training grant 5-TO-1-MH 12224 (to LCS) from the National Institute of Mental Health. 1 Graduate School of Biomedical Sciences, University of Texas at Houston, Houston, Texas 77025. 2M. D. Anderson Hospital and Tumor Institute, University of Texas at Houston, Houston, Texas 77025. 3 Texas Research Institute of Mental Sciences, Houston, Texas 77025. o 1972 by the American Society of Human Genetics. All rights reserved. 514 NEUROBLASTOMA AND PHEOCHROMOCYTOMA 515 TABLE 1 NEUROBLASTOMA: SEX AND AGE AT DIAGNOSIS FOR UNSELECTED AND FAMILIAL CASES UNSELECTED CASES* FAMILIAL CASESt AGE AT DIAGNOSIS Accumulated Accumulated (YEARS) N (%) N (%) 0-1 .......................... 130 26 14 56 1-2 .......................... 89 43 4 72 2-3 .......................... 74 58 4 88 3-4 .......................... 69 72 1 92 4-5 .......................... 48 81 1 96 5-6 .......................... 30 87 6-7 ....................... ... 16 90 ... ... 7-8 ....................... ... 8 92 ... ... 8-9 ....................... ... 13 95 ... ... 9-10 ......................... 4 96 ... ... >10 ......................... 23 ... 1 Total ...................... 504 ... 25 * [2]; N: male, 289 (57%); female, 215 (43%). t See table 2; N: male, 11; female, 14. in the early years (table 2), with 56% occurring by the end of the first year, and 4% after 5 years. The age at diagnosis is clearly much earlier in familial cases. Another difference between unselected and familial cases is that, while multiple cases constitute approximately 5%o of all neuroblastoma ([15], three of 60 cases from MDAH), they comprise 23%o of familial cases (table 2: five of 22 cases in which data are provided). An expected concomitant is that multiple tumor cases will occur earlier in life. Unfortunately, we do not have as much evidence on this point as needed. Most reports of large series do not provide this information. Those reports which do provide it are few in number and obviously biased toward the more spectacular phenomenon of congenital neuroblastoma. However, that interest- ing phenomenon itself provides the illuminating data that in 15%'o of 40 congenital cases both adrenal glands were involved [16]. According to the two-mutation model, all multiple tumor cases are hereditary. For retinoblastoma, this is borne out by the fact that 50%o of the offspring of surviving cases are affected [1]. For neuroblastoma, there is little evidence bearing directly upon this point, although there are three instances in which there may have been an affected parent [6, 10, 14]. In the family of Zimmerman [6], the father had a mediastinal ganglioneuroma removed at the age of 10 years. In the family reported by Chatten and Voorhess [10], the mother had elevated urinary catecholamines, as did the father in the family reported by Wong and his col- leagues [14]. A prediction of the model is that 50%o of the offspring of multiple tumor cases would be predisposed gene carriers. The probability that a gene carrier will develop neuroblastoma, i.e., the pene- trance, can be estimated by treatment of the solitary and multiple cases as a TABLE 2 NEUROBLASTOMA: FAMILIAL CASES PRIMARY SITES Adrenal AGE AT Sympa- REFERENCE DIAGNOSIS RELATION- No. thetic AND CASE No. (YEARS) SEX SHIP TUMORS Single Bilateral Chain [3]: 1 ............ 2 / F Proband 1 + ... *. 2 ............ NS F Sib NS ~~~~~~... .. ... [4]: 3 ............ 13 M Proband 1 + ... *. 4 ............ NS NS Sib NS ........ [5]: + 5 ............ 4 F Proband 1 .. 6 ............ 7/12 M Sib 1 + ... ..... [6]: 7* ........... 29412 M Proband 3 .. - + + 8 ............ 3/12 F Half-sib >2 . .. + .. [7]: 9 ............ 4/12 M Proband 1 + ... ..... 10 ............ 4/12 M Identical 1 + ... ..... twin [8]: 11 ............ NS NS Proband NS 12 ............ NS NS Identical NS twin [9]: 13 ............ 92 F Proband 1 14 ............ "A/12 F Identical I twin [10]: 15t ........... 1/12 M Proband 1 . .. 16 ........... 13/2 F Sib 3 + + .. 17 ........... 4/12 F Sib 4 + +(2) .. 18 ........... 5/12 F Sib 1 *.* + [11]: 19 ........... birth M Proband 1 + 20 ........... 1 M Sib 1 *. + 21 ........... 2 F Sib NS .. [12]: 22T ........... 42 F Proband 1 + 23 ........... birth F Sib 1 [13]: 24 ........... 13 days M Proband NS 25 ............ 1i2 M Identical NS twin NOTE.-NS = not stated. * One parent abnormal: father had mediastinal ganglioneuroma removed at age 10 years. t One parent abnormal: mother had markedly elevated urinary catecholamines but no demonstrable tumor. $ During the course of the family study, a 15-year-old sister was discovered to have elevated urinary cate- cholamines and a calcified adrenal. 516 NEUROBLASTOMA AND PHEOCHROMOCYTOMA 517 TABLE 2 (Continued) NEUROBLASTOMA: FAMILIAL CASES PRIMARY SITES AGE AT Adrenal Sympa- REFERENCE DIAGNOSIS RELATION- No. thetic AND CASE No. (YEARS) SEX S}IP TUMORS Single Bilateral Chain [14]: 26§ ........... 2 NS Proband 3 + ... ±(2) 27 ........... 52 F Sib 1 + ... ... Present report: 28 .......... 2 M Proband 1 + ... ... 29 .......... 3Y,2 F 2d cousin 1 + ... ... § One parent abnormal: father had significantly elevated urinary catecholamines but no demonstrable tumor. Poisson distribution. Thus, for a Poisson mean (m) of 1.0, the fraction of unaf- fected carriers (e-m) would be 0.37, that of gene carriers with one tumor (me-rn) would be 0.37, and that of multiple tumor cases would be the remainder, 0.26. Among those with any tumor (0.63), multiple cases (0.26) would constitute 41%. However, two tumors might occur at just one site, e.g., one adrenal gland. If only affected sites are counted and if just two sites are available, as with paired organs, then an expectation may be calculated (table 3) in which the fraction affected TABLE 3 EXPECTED DISTRIBUTIONS OF ADRENAL NEUROBLASTOMAS FOR A MEAN NUMBER (m) OF UNITY EXPECTED FREQUENCY TOTAL TUMORS POISSON FRACTION BOTH ADRENALS PROBABILITY UNILATERAL (r) (mre-m/r! ) [2(1/2)1] None Unilateral Bilateral 0 ................... 0.368 ... 0.368 1 ................... 0.368 1 ... 0.368 2 ................... 0.184 M ... 0.092 0.092 3 ................... 0.061 Y4 ... 0.015 0.046 4 ................... 0.015 1/8 ... 0.002 0.013 5 ................... 0.003 146 ... ... 0.003 Totals ............ 0.999 ... 0.368 0.477 0.154 unilaterally is 0.48 and that affected bilaterally is 0.15; and, among affected in- dividuals, bilateral cases are 24%o of the total. For neuroblastoma, the fraction of multiple cases among gene carriers is difficult to estimate. No cases are reported of two primaries at one site, but this may simply reflect failure of reporting. In ad- dition, the fraction of multiple cases is probably underestimated. It may be, there- 518 KNUDSON AND STRONG fore, that the observation of 23%o multiple tumors among familial cases is compatible with a Poisson mean of unity. If so, gene carriers would be affected 63 % of the time, and, among the offspring of bilateral cases, about 32% should be affected. The fraction of hereditary cases, fh, may be estimated by assuming that all mul- tiple cases are hereditary. If 5% of all cases are multiple and if 23%'o of familial cases are multiple, 0.23 f1 - 0.05, and fh 0.22 (i.e., 22%o of all cases of neuro- blastoma occur in gene carriers). Of course, nearly all of these cases have resulted from new germinal mutations. The incidental calculation can be made that, if 15% of congenital cases are multiple, then approximately 68%o of congenital cases are hereditary. The germinal mutation rate (jig) necessary to produce these gene carriers may be calculated from a knowledge of the incidence of neuroblastoma (i), the heredi- tary fraction (fh), the mean number of tumors (m), and the coefficient of selec- tion (s).
Recommended publications
  • Malignant Glioma Arising at the Site of an Excised Cerebellar Hemangioblastoma After Irradiation in a Von Hippel-Lindau Disease Patient

    Malignant Glioma Arising at the Site of an Excised Cerebellar Hemangioblastoma After Irradiation in a Von Hippel-Lindau Disease Patient

    DOI 10.3349/ymj.2009.50.4.576 Case Report pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 50(4): 576-581, 2009 Malignant Glioma Arising at the Site of an Excised Cerebellar Hemangioblastoma after Irradiation in a von Hippel-Lindau Disease Patient Na-Hye Myong1 and Bong-Jin Park2 1Department of Pathology, Dankook University College of Medicine, Cheonan; 2Department of Neurosurgery, Kyunghee University Hospital, Seoul, Korea. We describe herein a malignant glioma arising at the site of the resected hemangioblastoma after irradiation in a patient with von Hippel-Lindau disease (VHL). The patient was a 25 year-old male with multiple heman- gioblastomas at the cerebellum and spinal cord, multiple pancreatic cysts and a renal cell carcinoma; he was diagnosed as having VHL disease. The largest hemangioblastoma at the right cerebellar hemisphere was completely removed, and he received high-dose irradiation postoperatively. The tumor recurred at the same site 7 years later, which was a malignant glioma with no evidence of hemangioblastoma. The malignant glioma showed molecular genetic profiles of radiation-induced tumors because of its diffuse p53 immunostaining and the loss of p16 immunoreactivity. The genetic study to find the loss of heterozygosity (LOH) of VHL gene revealed that only the cerebellar hemangioblastoma showed allelic losses for the gene. To the best of our knowledge, this report is the first to show a malignant glioma that developed in a patient with VHL disease after radiation therapy at the site of an excised hemangioblastoma. This report also suggests that radiation therapy should be performed very carefully in VHL patients with hemangioblastomas.
  • Current Diagnostic and Therapeutic Strategies in Treatment of CNS Hemangioblastomas in Patients with VHL

    Current Diagnostic and Therapeutic Strategies in Treatment of CNS Hemangioblastomas in Patients with VHL

    Journal of Central Translational Medicine & Epidemiology Special Issue on von Hippel Lindau Disease Edited by: Hiroshi Kanno Professor, Department of Neurosurgery, Yokohama City University School of Medicine, Japan Review Article *Corresponding author Sven Gläsker, Department of Neurosurgery, Freiburg University Medical Center, Breisacher Str. 64, D-79106, Current Diagnostic and Freiburg, Germany, Tel: 49(0)761-270-50010; Fax: 49(0)761-270-50080; Email: Therapeutic Strategies Submitted: 11 November 2013 Accepted: 03 January 2014 in Treatment of CNS Published: 06 January 2014 Copyright Hemangioblastomas in Patients © 2014 Gläsker et al. OPEN ACCESS with VHL Keywords • Hemangioblastoma Marie T. Krüger1, Jan-Helge Klingler1, Christine Steiert1, Cordula • von Hippel-Lindau disease Jilg2, Stefan Zschiedrich3, Birke Bausch4, Vera Van Velthoven1 and • Surgical treatment • Diagnosis; Follow-up Sven Gläsker1* 1Department of Neurosurgery, Freiburg University Medical Center, Germany 2Department of Urology, Freiburg University Medical Center, Germany 3Department of Internal Medicine, Freiburg University Medical Center, Germany 42nd Department of Internal Medicine, Freiburg University Medical Center, Germany Abstract Hemangioblastomas are a rare form of benign vascular tumors of the CNS. They can occur sporadically or as component of the von Hippel-Lindau (VHL) disease - an autosomal dominant tumor syndrome. The tumors are typically located in the posterior fossa and spinal cord. Patients with associated VHL disease are usually affected at an early age and develop multiple lesions. Therefore they need a special routine for diagnosis, treatment and follow-up strategies. In modern neurosurgery, hemangioblastomas are well resectable tumors. Symptomatic lesions should be removed. Resection should furthermore be considered for asymptomatic progressive tumors for the following reason: If a tumor has already caused neurological deficits, the chance to reverse these by surgical resection is reduced and surgical resection is usually possible with low morbidity.
  • Endocrine Pathology (537-577)

    Endocrine Pathology (537-577)

    LABORATORY INVESTIGATION THE BASIC AND TRANSLATIONAL PATHOLOGY RESEARCH JOURNAL LI VOLUME 99 | SUPPLEMENT 1 | MARCH 2019 2019 ABSTRACTS ENDOCRINE PATHOLOGY (537-577) MARCH 16-21, 2019 PLATF OR M & 2 01 9 ABSTRACTS P OSTER PRESENTATI ONS EDUCATI ON C O M MITTEE Jason L. Hornick , C h air Ja mes R. Cook R h o n d a K. Y a nti s s, Chair, Abstract Revie w Board S ar a h M. Dr y and Assign ment Co m mittee Willi a m C. F a q ui n Laura W. La mps , Chair, C ME Subco m mittee C ar ol F. F ar v er St e v e n D. Billi n g s , Interactive Microscopy Subco m mittee Y uri F e d ori w Shree G. Shar ma , Infor matics Subco m mittee Meera R. Ha meed R aj a R. S e et h al a , Short Course Coordinator Mi c h ell e S. Hir s c h Il a n W ei nr e b , Subco m mittee for Unique Live Course Offerings Laksh mi Priya Kunju D a vi d B. K a mi n s k y ( Ex- Of ici o) A n n a M ari e M ulli g a n Aleodor ( Doru) Andea Ri s h P ai Zubair Baloch Vi nita Parkas h Olca Bast urk A nil P ar w a ni Gregory R. Bean , Pat h ol o gist-i n- Trai ni n g D e e p a P atil D a ni el J.
  • Central Nervous System Tumors General ~1% of Tumors in Adults, but ~25% of Malignancies in Children (Only 2Nd to Leukemia)

    Central Nervous System Tumors General ~1% of Tumors in Adults, but ~25% of Malignancies in Children (Only 2Nd to Leukemia)

    Last updated: 3/4/2021 Prepared by Kurt Schaberg Central Nervous System Tumors General ~1% of tumors in adults, but ~25% of malignancies in children (only 2nd to leukemia). Significant increase in incidence in primary brain tumors in elderly. Metastases to the brain far outnumber primary CNS tumors→ multiple cerebral tumors. One can develop a very good DDX by just location, age, and imaging. Differential Diagnosis by clinical information: Location Pediatric/Young Adult Older Adult Cerebral/ Ganglioglioma, DNET, PXA, Glioblastoma Multiforme (GBM) Supratentorial Ependymoma, AT/RT Infiltrating Astrocytoma (grades II-III), CNS Embryonal Neoplasms Oligodendroglioma, Metastases, Lymphoma, Infection Cerebellar/ PA, Medulloblastoma, Ependymoma, Metastases, Hemangioblastoma, Infratentorial/ Choroid plexus papilloma, AT/RT Choroid plexus papilloma, Subependymoma Fourth ventricle Brainstem PA, DMG Astrocytoma, Glioblastoma, DMG, Metastases Spinal cord Ependymoma, PA, DMG, MPE, Drop Ependymoma, Astrocytoma, DMG, MPE (filum), (intramedullary) metastases Paraganglioma (filum), Spinal cord Meningioma, Schwannoma, Schwannoma, Meningioma, (extramedullary) Metastases, Melanocytoma/melanoma Melanocytoma/melanoma, MPNST Spinal cord Bone tumor, Meningioma, Abscess, Herniated disk, Lymphoma, Abscess, (extradural) Vascular malformation, Metastases, Extra-axial/Dural/ Leukemia/lymphoma, Ewing Sarcoma, Meningioma, SFT, Metastases, Lymphoma, Leptomeningeal Rhabdomyosarcoma, Disseminated medulloblastoma, DLGNT, Sellar/infundibular Pituitary adenoma, Pituitary adenoma,
  • Adrenal Neuroblastoma Mimicking Pheochromocytoma in an Adult With

    Adrenal Neuroblastoma Mimicking Pheochromocytoma in an Adult With

    Khalayleh et al. Int Arch Endocrinol Clin Res 2017, 3:008 Volume 3 | Issue 1 International Archives of Endocrinology Clinical Research Case Report : Open Access Adrenal Neuroblastoma Mimicking Pheochromocytoma in an Adult with Neurofibromatosis Type 1 Harbi Khalayleh1, Hilla Knobler2, Vitaly Medvedovsky2, Edit Feldberg3, Judith Diment3, Lena Pinkas4, Guennadi Kouniavsky1 and Taiba Zornitzki2* 1Department of Surgery, Hebrew University Medical School of Jerusalem, Israel 2Endocrinology, Diabetes and Metabolism Institute, Kaplan Medical Center, Hebrew University Medical School of Jerusalem, Israel 3Pathology Institute, Kaplan Medical Center, Israel 4Nuclear Medicine Institute, Kaplan Medical Center, Israel *Corresponding author: Taiba Zornitzki, MD, Endocrinology, Diabetes and Metabolism Institute, Kaplan Medical Center, Hebrew University Medical School of Jerusalem, Bilu 1, 76100 Rehovot, Israel, Tel: +972-894- 41315, Fax: +972-8 944-1912, E-mail: [email protected] Context 2. This is the first reported case of an adrenal neuroblastoma occurring in an adult patient with NF1 presenting as a large Neurofibromatosis type 1 (NF1) is a genetic disorder asso- adrenal mass with increased catecholamine levels mimicking ciated with an increased risk of malignant disorders. Adrenal a pheochromocytoma. neuroblastoma is considered an extremely rare tumor in adults and was not previously described in association with NF1. 3. This case demonstrates the clinical overlap between pheo- Case description: A 42-year-old normotensive woman with chromocytoma and neuroblastoma. typical signs of NF1 underwent evaluation for abdominal pain, Keywords and a large 14 × 10 × 16 cm left adrenal mass displacing the Adrenal neuroblastoma, Neurofibromatosis type 1, Pheo- spleen, pancreas and colon was found. An initial diagnosis of chromocytoma, Neural crest-derived tumors pheochromocytoma was done based on the known strong association between pheochromocytoma, NF1 and increased catecholamine levels.
  • Choroid Plexus Papilloma Arising from the Temporal Horn with a Bilateral Hypersecretory Hydrocephalus: a Case Report and Review of Literature

    Choroid Plexus Papilloma Arising from the Temporal Horn with a Bilateral Hypersecretory Hydrocephalus: a Case Report and Review of Literature

    Elmer ress Case Report World J Oncol. 2016;7(2-3):51-56 Choroid Plexus Papilloma Arising From the Temporal Horn With a Bilateral Hypersecretory Hydrocephalus: A Case Report and Review of Literature Sureswar Mohantya, Suman Saurav Routb, d, Gouri Sankar Sarangia, Kumudini Devic Abstract occur in the third ventricle. These tumors are benign histologi- cally and are neuroectodermal in origin and assigned a WHO Cerebrospinal fluid (CSF) within the cerebral ventricular system is grade I. Complete or gross total resection of these tumors often secreted by a neuroepithelial tissue which is called as the choroid results in a cure and almost recurrence free survival. The spe- plexus. Tumors arising from these tissues are rare. Choroid plexus cial challenges in the management of these tumors are mostly papillomas (CPPs) have been denoted as WHO grade I of the cho- due to its several unique features which include the young age roid plexus tumors. Among the intracranial tumors, neoplasms of the at presentation, high vascularity of these tumors and the poten- choroid plexus constitute around 0.36-0.6%. CPPs are mostly slow tial for hypersecretion of CSF. growing and cause symptoms due to mass effect and obstructive hy- drocephalus, resulting in increased intracranial pressure. We report a Case Report case of CPP arising from the temporal horn in a 7-year-old girl pre- senting with progressive head enlargement since birth due to bilateral massive hydrocephalus without any obstruction, making it purely a A 7-year-old girl presented with progressive head enlargement hypersecretory hydrocephalus. A drainage procedure followed by since birth, features of raised intracranial pressure in the form complete tumor resection was carried out in our case and the patient of headache, vomiting, excessive crying and excessive drowsi- showed marked relief from her symptoms.
  • Cerebellar Neuroblastoma in 2.5 Years Old Child

    Cerebellar Neuroblastoma in 2.5 Years Old Child

    Case Report Cerebellar Neuroblastoma in 2.5 Years Old Child Mohammad Pedram1, Majid Vafaie1, Kiavash Fekri1, Sabahat Haghi1, Iran Rashidi2, Chia Pirooti3 Abstract 1. Thalassemia and Neuroblastoma is the third most common malignancy of childhood, after leukemia Hemoglobinopathy Research Center, Ahvaz Jondishapur University of and brain tumors. Only 2% of all neuroblastoma occur in the brain. Primary Medical Sciences, Ahvaz, Iran cerebellar neuroblastoma is an specific subset of Primitive Neuroectodermal 2. Dept. of Pathology, Shafa Tumors (PNET). Meduloblastoma is a relatively common and well-established Hospital , Ahvaz Jondishapur entity, consisting of primitive and multipotential cells that may exhibit some University of Medical Sciences, evidence of neuroblastic or gliad differentiation. But cerebellar neuroblastoma Ahvaz, Iran with ultrastractural evidence of significant neuroblastic differentiation is 3. Dept. of Neurosurgery, Golestan extremely rare. We report a rare case of neuroblastoma in the cerebellum. A Hospital, Ahvaz Jondishapur 2.5-year-old Iranian boy presented with vomiting and nausea in the morning and University of Medical Sciences, ataxia. CT scan showed a tumor mass in the cerebellum and the report of Ahvaz, Iran radiologist was medulloblastoma. Light microscopic assay showed a small cell Corresponding Author: neoplasm with lobules of densely packed cells (lobulated pattern) and better Mohammad Pedram, MD; differentiated cells. Neuron-Specific Enolase was positive. Pathologic diagnosis Professor of Pediatrics Hematology- confirmed the existence of cerebellar neuroblastoma. Chemotherapy followed Oncology surgical removal. No relapse occurred 12 months after surgery. Tel: (+98) 611 374 32 85 Email: Keywords: Neuroblastoma; Cerebellum; Chemotherapy [email protected] Please cite this article as: Pedram M, Vafaie M, Fekri K, Haghi S, Rashidi I, Pirooti Ch.
  • Synchronous Primary Hyperparathyroidism and Papillary Thyroid Carcinoma in a 50-Year-Old Female, Who Initially Presented with Uncontrolled Hypertension

    Synchronous Primary Hyperparathyroidism and Papillary Thyroid Carcinoma in a 50-Year-Old Female, Who Initially Presented with Uncontrolled Hypertension

    Open Access http://www.jparathyroid.com Journal of Journal of Parathyroid Disease 2014,2(2),69–70 Epidemiology and Prevention Synchronous primary hyperparathyroidism and papillary thyroid carcinoma in a 50-year-old female, who initially presented with uncontrolled hypertension Seyed Seifollah Beladi Mousavi1, Hamid Nasri2*, Saeed Behradmanesh3 hough, the association between parathyroid and Implication for health policy/practice/research/ thyroid diseases is not uncommon, however medical education concurrent presence of parathyroid adenoma An association between parathyroid adenoma Tand thyroid cancer is rare (1,2). The association between and thyroid cancer is rare. Awareness of this concurrent thyroid and parathyroid disease was firstly situation will enable clinicians to consider for explained by Kissin et al. in 1947 (2). Awareness of possible thyroid pathology in patients with primary this situation will enable clinicians to consider for hyperparathyroidism. Both of these endocrine diseases possible thyroid pathology in patients with primary could then be managed with a single surgery involving hyperparathyroidism. While thyroid follicular cells and concomitant resection of the thyroid and involved parathyroid cells are embryologically different. It is evident parathyroid glands. that presence of parathyroid adenoma leading to primary hyperparathyroidism and coexistent of thyroid papillary cancer is rare. Both of these endocrine diseases could then coincidence of papillary thyroid carcinoma. After surgery, be managed with a single surgery involving concomitant serum parathormone and calcium returned to their normal resection of the thyroid and involved parathyroid glands. values and patient was referred to an endocrinologist for A 50-year-old female, referred to the nephrology clinic for continuing the treatment of papillary carcinoma.
  • Parathyroid Carcinoma Presenting As an Acute Pancreatitis

    Parathyroid Carcinoma Presenting As an Acute Pancreatitis

    International Journal of Radiology & Radiation Therapy Case Report Open Access Parathyroid carcinoma presenting as an acute pancreatitis Abstract Volume 3 Issue 3 - 2017 Parathyroid carcinoma is the cause of only 1% of hyperparathyroidism cases. The Enrique Cadena,1,2,3 Alfredo Romero-Rojas1,3 incidence of acute pancreatitis in patients with hyperparathyroidism was reported to 1Department of Head and Neck Surgery and Pathology, be only 1.5%. The occurrence of pancreatitis in patients with parathyroid carcinoma National Cancer Institute, Colombia is unusual, ranging from 0% to 15%. Here, we report a very rare case of parathyroid 2Department of Surgery, National University of Colombia, carcinoma presenting as an acute pancreatitis in a 45years old woman, who was Colombia suspected for hypercalcemia and higher levels of intact parathyroid hormone. The 3Department of Head and Neck Surgery and Pathology, Marly parathyroid carcinoma was verified with ultrasound, CT Scan, and single-photon Clinic, Colombia emission computed tomography. The pathological anatomy report showed a minimally invasive parathyroid carcinoma. Following surgery, the patient was free after almost Correspondence: Enrique Cadena, Department of Head and a 4years follow up. Neck Surgery and Pathology, National Cancer Institute, Bogotá, 1st Street # 9-85, Colombia, Tel 5713341111, 5713341478, Keywords: acute necrotizing pancreatitis, hypercalcemia, primary Email [email protected] hyperparathyroidism, parathyroid carcinoma Received: May 29, 2017 | Published: June 27, 2017 Abbreviations: HPT, hyperparathyroidism; PHPT, primary (2.5mg/dl) levels. Kidney and liver function tests, albumin and hyperparathyroidism; SPECT, single-photon emission computed to- triglyceride levels were all within normal limits. The patient was mography; CT, computed tomography; iPTH, intact parathyroid hor- treated initially with intravenous fluids and H2 blockers, and no oral mone.
  • Stereotactic Radiosurgery in Hemangioblastoma

    Stereotactic Radiosurgery in Hemangioblastoma

    Published online: 2019-09-25 Original Article Stereotactic radiosurgery in hemangioblastoma: Experience over 14 years Nishant Goyal, Deepak Agrawal, Raghav Singla, Shashank Sharad Kale, Manmohan Singh, Bhawani Shankar Sharma Department of Neurosurgery and Gamma Knife, All India Institute of Medical Sciences, New Delhi, India ABSTRACT Background: Although gamma knife has been advocated for hemangioblastomas, it is not used widely by neurosurgeons. Objective: We review our experience over 14 years in an attempt to define the role of stereotactic radiosurgery (SRS) in the management of hemangioblastomas. Patients and Methods: A retrospective study was conducted on all patients of hemangioblastoma who underwent SRS at our institute over a period of 14 years (1998–2011). Gamma knife plans, clinical history, and radiology were reviewed for all patients. Results: A total of 2767 patients underwent gamma knife during the study period. Of these, 10 (0.36%) patients were treated for 24 hemangioblastomas. Eight patients (80%) had von Hippel‑Lindau disease while two had sporadic hemangioblastomas. The median peripheral dose (50% isodose) delivered to the tumors was 29.9 Gy. Clinical and radiological follow‑up data were available for eight patients. Of these, two were re‑operated for persisting cerebellar symptoms. The remaining six patients were recurrence‑free at a mean follow‑up of 48 months (range 19–108 months). One patient had an increase in cyst volume along with a decrease in the size of the mural nodule. Conclusions: SRS should be the first option for asymptomatic hemangioblastomas. Despite the obvious advantages, gamma knife is not widely used as an option for hemangioblastomas. Key words: Gamma knife radiosurgery, hemangioblastomas, stereotactic radiosurgery, von Hippel‑Lindau syndrome Introduction view of site, vascularity, and number.
  • Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: an Overview Comparing Pediatric and Adult Populations

    Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: an Overview Comparing Pediatric and Adult Populations

    cancers Review Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations 1, 2, 2 3 Aline Rangel-Pozzo y, Luiza Sisdelli y, Maria Isabel V. Cordioli , Fernanda Vaisman , Paola Caria 4,*, Sabine Mai 1,* and Janete M. Cerutti 2 1 Cell Biology, Research Institute of Oncology and Hematology, University of Manitoba, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada; [email protected] 2 Genetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo/EPM, São Paulo, SP 04039-032, Brazil; [email protected] (L.S.); [email protected] (M.I.V.C.); [email protected] (J.M.C.) 3 Instituto Nacional do Câncer, Rio de Janeiro, RJ 22451-000, Brazil; [email protected] 4 Department of Biomedical Sciences, University of Cagliari, 09042 Cagliari, Italy * Correspondence: [email protected] (P.C.); [email protected] (S.M.); Tel.: +1-204-787-2135 (S.M.) These authors contributed equally to this paper. y Received: 29 September 2020; Accepted: 26 October 2020; Published: 27 October 2020 Simple Summary: Papillary thyroid carcinoma (PTC) represents 80–90% of all differentiated thyroid carcinomas. PTC has a high rate of gene fusions and mutations, which can influence clinical and biological behavior in both children and adults. In this review, we focus on the comparison between pediatric and adult PTC, highlighting genetic alterations, telomere-related genomic instability and changes in nuclear organization as novel biomarkers for thyroid cancers. Abstract: Thyroid cancer is a rare malignancy in the pediatric population that is highly associated with disease aggressiveness and advanced disease stages when compared to adult population.
  • Ganglioneuroblastoma As Vasoactive Intestinal Polypeptide-Secreting10.5005/Jp-Journals-10002-1167 Tumor: Rare Case Report in a Child Case Report

    Ganglioneuroblastoma As Vasoactive Intestinal Polypeptide-Secreting10.5005/Jp-Journals-10002-1167 Tumor: Rare Case Report in a Child Case Report

    WJOES Ganglioneuroblastoma as Vasoactive Intestinal Polypeptide-secreting10.5005/jp-journals-10002-1167 Tumor: Rare Case Report in a Child CASE REPORT Ganglioneuroblastoma as Vasoactive Intestinal Polypeptide-secreting Tumor: Rare Case Report in a Child 1Basant Kumar, 2Vijai D Upadhyaya, 3Ram Nawal Rao, 4Sheo Kumar ABSTRACT than 60 cases of pediatric VIP-secreting tumors.3 Most Pathologically elevated vasoactive intestinal polypeptide (VIP) of them are either adrenal pheochromocytoma or mixed plasma levels cause secretory diarrhea with excessive loss of pheochromocytoma-ganglioneuroma tumors. Mason water and electrolyte and is characterized by the typical symp- et al,4 first described the secretory nature of neuroblas- toms of hypokalemia and metabolic acidosis. It rarely occurs toma and vasoactive intestinal peptide (VIP) can be in patients with non-pancreatic disease. Despite the clinical severity, diagnosis of a VIP-secreting tumor is often delayed. produced by the mature neurogenic tumors. We herein We herein present a 14-month-old boy having prolonged present a 14 months old boy having prolonged therapy- therapy-resistant secretory diarrhea, persistent hypokalemia resistant secretory diarrhea, persistent hypokalemia with with tissue diagnosis of ganglioneuroblastoma and raised plasma VIP-levels. tissue diagnosis of ganglioneuroblastoma and briefly review the literature. Keywords: Ganglioneuroblastoma, Secretory diarrhea, VIPoma. CASE REPORT How to cite this article: Kumar B, Upadhyaya VD, Rao RN, Kumar S. Ganglioneuroblastoma as Vasoactive Intestinal A 14-month-old boy, weighing 9 kg with advanced symp- Polypeptide-secreting Tumor: Rare Case Report in a Child. World J Endoc Surg 2015;7(2):47-50. toms of persistent secretory diarrhea, hypokalemia and metabolic acidosis was referred to us with radiological Source of support: Nil (computed tomography) diagnosis of retroperitoneal Conflict of interest: None mass.